mhurhangee/ep-ind-claims huggingface dataset:
A method for discontinuous reception, comprising: monitoring, by a first terminal device, a physical downlink control channel, PDCCH, characterized in that the PDCCH carries m pieces of discontinuous reception, DRX, information respectively for m terminal devices, one of the m terminal devices being the first terminal device, wherein m is a positive integer and greater than one, wherein, each piece of DRX information in the m pieces of DRX information is used for indicating: a target bandwidth part, BWP, used after the DRX information, and a time length for monitoring a PDCCH in an on-duration of a DRX cycle. monitoring, by a first terminal device, a physical downlink control channel, PDCCH, characterized in that the PDCCH carries m pieces of discontinuous reception, DRX, information respectively for m terminal devices, one of the m terminal devices being the first terminal device, wherein m is a positive integer and greater than one, wherein, each piece of DRX information in the m pieces of DRX information is used for indicating: a target bandwidth part, BWP, used after the DRX information, and a time length for monitoring a PDCCH in an on-duration of a DRX cycle.
An implement hitch for a tractor, wherein the hitch is fitted with a mechanism for stabilising lateral movement of lifting arms (12,14) of the hitch, which lifting arms (12,14) are connected to be raised and lowered by respective hydraulic cylinders (16,18), and wherein the stabilising mechanism (22,24) has a locking pin that is automatically retracted to an unlocked position by means of a flexible linkage when the lifting arms are in a lowered position, characterised in that the opposite end of the flexible linkage from the locking pin is connected to an anchoring point provided on the hydraulic cylinder serving to raise and lower one of the lifting arms.
An antibody molecule for use in treating systemic sclerosis, wherein the antibody molecule binds to and neutralizes human TGFβ1, TGFβ2 and TGFβ3, and wherein the antibody molecule comprises: (i) a heavy chain comprising a heavy chain variable domain, wherein the VH domain comprises the amino acid sequence of SEQ ID NO: 2, and a human IgG 4 constant region, and (ii) a light chain comprising a light chain variable domain, wherein the VL domain comprises the amino acid sequence of SEQ ID NO: 7. wherein the antibody molecule binds to and neutralizes human TGFβ1, TGFβ2 and TGFβ3, and wherein the antibody molecule comprises: (i) a heavy chain comprising a heavy chain variable domain, wherein the VH domain comprises the amino acid sequence of SEQ ID NO: 2, and a human IgG 4 constant region, and (ii) a light chain comprising a light chain variable domain, wherein the VL domain comprises the amino acid sequence of SEQ ID NO: 7. (i) a heavy chain comprising a heavy chain variable domain, wherein the VH domain comprises the amino acid sequence of SEQ ID NO: 2, and a human IgG 4 constant region, and (ii) a light chain comprising a light chain variable domain, wherein the VL domain comprises the amino acid sequence of SEQ ID NO: 7.
A method for selectively enabling normal acknowledgement, ACK, block ACK, BA, or no ACK for wireless transmissions using a Physical Layer Protocol Data Unit, PPDU, the method comprising: setting at least one designated bit in a Physical Layer, PHY, header of the PPDU in a radio frame for transmission from a transmitter to a plurality of receivers to indicate an ACK type for response, selected from at least two of a normal ACK, a Block ACK, or no ACK, wherein the normal ACK applies to every Media Access Control, MAC, Protocol Data Unit, MPDU, associated with the PPDU, and wherein the Block ACK applies to multiple MPDUs associated with the PPDU and wherein an indication of the ACK type for response is not contained in any MPDU of the PPDU; and transmitting the PPDU in the radio frame to the plurality of receivers; and selecting a Signal, SIG, field for indicating the ACK type comprising a field that is transmitted to each of multiple receivers individually or a field that is transmitted to all of multiple receivers. setting at least one designated bit in a Physical Layer, PHY, header of the PPDU in a radio frame for transmission from a transmitter to a plurality of receivers to indicate an ACK type for response, selected from at least two of a normal ACK, a Block ACK, or no ACK, wherein the normal ACK applies to every Media Access Control, MAC, Protocol Data Unit, MPDU, associated with the PPDU, and wherein the Block ACK applies to multiple MPDUs associated with the PPDU and wherein an indication of the ACK type for response is not contained in any MPDU of the PPDU; and transmitting the PPDU in the radio frame to the plurality of receivers; and selecting a Signal, SIG, field for indicating the ACK type comprising a field that is transmitted to each of multiple receivers individually or a field that is transmitted to all of multiple receivers.
A method performed by a remote unit, comprising: receiving a downlink control information, DCI, for scheduling time-contiguous data transmission in multiple slots, wherein the DCI includes an indicator indicating the time domain resource allocation in the multiple slots; determining, based on the indicator, a starting position and an ending position of the scheduled time-contiguous data transmission; and transmitting data from the determined starting position to the determined ending position; wherein the data are transmitted in response to a successful listen-before-talk, LBT, and characterized in that the indicator includes separate indications of PUSCH mapping types for a first slot, a last slot and middle slot(s) of the multiple slots. receiving a downlink control information, DCI, for scheduling time-contiguous data transmission in multiple slots, wherein the DCI includes an indicator indicating the time domain resource allocation in the multiple slots; determining, based on the indicator, a starting position and an ending position of the scheduled time-contiguous data transmission; and transmitting data from the determined starting position to the determined ending position; wherein the data are transmitted in response to a successful listen-before-talk, LBT, and characterized in that the indicator includes separate indications of PUSCH mapping types for a first slot, a last slot and middle slot(s) of the multiple slots.
A composition comprising: an ethylene/α-olefin copolymer comprising (i) ethylene and (ii) from 20 wt% to 35 wt% C 6 -C 8 α-olefin comonomer, the ethylene/α-olefin copolymer having a density from 0.880 g/cc to 0.895 g/cc; a melt viscosity, at 177°C, from 4,000 mPa•s to 20,000 mPa•s; a glass transition temperature from -55°C to -20°C; wherein the glass transition temperature is measured by Differential Scanning Calorimetry; a tackifier; and a wax. an ethylene/α-olefin copolymer comprising (i) ethylene and (ii) from 20 wt% to 35 wt% C 6 -C 8 α-olefin comonomer, the ethylene/α-olefin copolymer having a density from 0.880 g/cc to 0.895 g/cc; a melt viscosity, at 177°C, from 4,000 mPa•s to 20,000 mPa•s; a glass transition temperature from -55°C to -20°C; wherein the glass transition temperature is measured by Differential Scanning Calorimetry; a density from 0.880 g/cc to 0.895 g/cc; a melt viscosity, at 177°C, from 4,000 mPa•s to 20,000 mPa•s; a glass transition temperature from -55°C to -20°C; wherein the glass transition temperature is measured by Differential Scanning Calorimetry; a tackifier; and a wax.
A system comprising: means for storing a set of tokens for a current version of a document; means for tokenizing a new version of the document; means for generating a set of tokens for the new version of the document; means for determining one or more tokens to use to index the document, based on identified differences between the set of tokens for the new version of the document and the set of tokens for the current version of the document; means for generating an index mutation comprising the one or more tokens to use to index the document; means for storing the index mutation in association with a timestamp in an index mutation journal; means for storing, in the index mutation journal, the index mutation in association with an identifier of a document namespace to which the document belongs; means for identifying the index mutation in the index mutation journal as being for an index server, based on the document namespace identifier associated with the index mutation in the index mutation journal, wherein the index server indexes one or more documents belonging to the document namespace; and means for providing the one or more tokens to use to index the document, to the index server, from the index mutation in the index mutation journal, if the timestamp associated with the index mutation in the index mutation journal is more recent than a timestamp specified by the index server. means for storing a set of tokens for a current version of a document; means for tokenizing a new version of the document; means for generating a set of tokens for the new version of the document; means for determining one or more tokens to use to index the document, based on identified differences between the set of tokens for the new version of the document and the set of tokens for the current version of the document; means for generating an index mutation comprising the one or more tokens to use to index the document; means for storing the index mutation in association with a timestamp in an index mutation journal; means for storing, in the index mutation journal, the index mutation in association with an identifier of a document namespace to which the document belongs; means for identifying the index mutation in the index mutation journal as being for an index server, based on the document namespace identifier associated with the index mutation in the index mutation journal, wherein the index server indexes one or more documents belonging to the document namespace; and means for providing the one or more tokens to use to index the document, to the index server, from the index mutation in the index mutation journal, if the timestamp associated with the index mutation in the index mutation journal is more recent than a timestamp specified by the index server.
Cartridge for a nebulizer with a connecting element, the cartridge comprising: a container containing a fluid to be nebulized, a closure with a connection port for fluidically and/or sealingly connecting the container to the nebulizer or a delivery mechanism thereof, wherein a pierceable or breakable membrane or sealing wall is preferably integrated or arranged within the closure, in particular the connection port, characterized in that the cartridge comprises a sealing element between the closure and the container for forming a sealing inbetween, wherein the sealing element is adapted to sealingly receive the connecting element of the nebulizer after passing through the connection port. a container containing a fluid to be nebulized, a closure with a connection port for fluidically and/or sealingly connecting the container to the nebulizer or a delivery mechanism thereof, wherein a pierceable or breakable membrane or sealing wall is preferably integrated or arranged within the closure, in particular the connection port, characterized in that the cartridge comprises a sealing element between the closure and the container for forming a sealing inbetween, wherein the sealing element is adapted to sealingly receive the connecting element of the nebulizer after passing through the connection port.
A method of wireless communication for mitigating ambiguous interpretation of downlink control information, DCI, when a physical downlink control channel, PDCCH, candidate is transmitted in a user equipment specific search space, UESS, or in a common search space, CSS, comprising: determining a first aggregation level having a number of control channel elements, CCEs, used for transmitting a first downlink control information in a first search space; transmitting a second downlink control information in a second search space using a second aggregation level having a lower value than the first aggregation level, wherein the second search space is enclosed within the first search space, and wherein a payload size and a starting CCE for transmitting the first downlink control information in the first search space are the same as a payload size and a starting CCE for transmitting the second downlink control information in the second search space; wherein the first search space is one of the UESS and the CSS, and the second search space is the other one; determining at least one CCE of the first aggregation level not used for transmitting the first downlink control information; and transmitting interference on the at least one unused CCE to degrade decoding of the first downlink control information in the first search space, leading to a UE to select the intended PDCCH candidate in the second space. determining a first aggregation level having a number of control channel elements, CCEs, used for transmitting a first downlink control information in a first search space; transmitting a second downlink control information in a second search space using a second aggregation level having a lower value than the first aggregation level, wherein the second search space is enclosed within the first search space, and wherein a payload size and a starting CCE for transmitting the first downlink control information in the first search space are the same as a payload size and a starting CCE for transmitting the second downlink control information in the second search space; wherein the first search space is one of the UESS and the CSS, and the second search space is the other one; determining at least one CCE of the first aggregation level not used for transmitting the first downlink control information; and transmitting interference on the at least one unused CCE to degrade decoding of the first downlink control information in the first search space, leading to a UE to select the intended PDCCH candidate in the second space.
A compound of general formula, or a pharmaceutically acceptable salt, stereoisomer, biohydrolyzable amide, ester, carbamate, carbonate, ureide, phosphate or solvate thereof: wherein R 1 is selected from the group consisting of substituted or unsubstituted aryl and substituted or unsubstituted heteroaryl; R 2 and R 3, identical or different, are selected from the group consisting of hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkylalkyl, and substituted or unsubstituted alkenyl; or R 2 and R 3 form together with the bridging nitrogen atom to which they are attached a substituted or unsubstituted non-aromatic heterocyclyl, wherein the alkyl, cycloalkyl, alkenyl, aryl, heteroaryl or heterocyclyl groups may be independently substituted at one or more available positions by one or more suitable groups selected from OR', =O, SR', SOR', SO 2 R', OSO 2 R', OSO 3 R', NO 2, NHR', N(R') 2, =N-R', N(R')COR', N(COR') 2, N(R')SO 2 R', N(R')C(=NR')N(R')R', N 3, CN, halogen, COR', COOR', OCOR', OCOOR', OCONHR', OCON(R') 2, CONHR', CON(R') 2, PO(OR') 2, PO(OR')R', C 1 -C 12 alkyl, C 3 -C 10 cycloalkyl, C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, aryl, heteroaryl and non-aromatic heterocyclic group, wherein each of the R' groups is independently selected from the group consisting of hydrogen, OH, NH 2, SH, CN, halogen, COH, COalkyl, COOH, C 1 -C 12 alkyl, C 3 -C 10 cycloalkyl, C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, aryl, heteroaryl and non-aromatic heterocyclic group. R 1 is selected from the group consisting of substituted or unsubstituted aryl and substituted or unsubstituted heteroaryl; R 2 and R 3, identical or different, are selected from the group consisting of hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkylalkyl, and substituted or unsubstituted alkenyl; or R 2 and R 3 form together with the bridging nitrogen atom to which they are attached a substituted or unsubstituted non-aromatic heterocyclyl, wherein the alkyl, cycloalkyl, alkenyl, aryl, heteroaryl or heterocyclyl groups may be independently substituted at one or more available positions by one or more suitable groups selected from OR', =O, SR', SOR', SO 2 R', OSO 2 R', OSO 3 R', NO 2, NHR', N(R') 2, =N-R', N(R')COR', N(COR') 2, N(R')SO 2 R', N(R')C(=NR')N(R')R', N 3, CN, halogen, COR', COOR', OCOR', OCOOR', OCONHR', OCON(R') 2, CONHR', CON(R') 2, PO(OR') 2, PO(OR')R', C 1 -C 12 alkyl, C 3 -C 10 cycloalkyl, C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, aryl, heteroaryl and non-aromatic heterocyclic group, wherein each of the R' groups is independently selected from the group consisting of hydrogen, OH, NH 2, SH, CN, halogen, COH, COalkyl, COOH, C 1 -C 12 alkyl, C 3 -C 10 cycloalkyl, C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, aryl, heteroaryl and non-aromatic heterocyclic group.
A silicon micro-electromechanical resonator suspended from an anchor, wherein the shape of the resonator consists of two isosceles trapezoids adjoining at their narrow ends, thereby forming a bow-tie shape, such that the resonator is symmetric about its longitudinal axis, and about the anchor, the resonator having a thickness out of the plane of the resonator and having, in a plan view of the resonator: a length Lopt of each isosceles trapezoid; a minimum width w1 at the anchor; and a maximum width w2 at a free end of the resonator, a distance from the anchor, wherein the width of the resonator tapers gradually along its entire length from the maximum width to the minimum width, and wherein the dimensions of the resonator satisfy one of the following two equations: L opt w 1 = - 0.1327 ⁢ φ - 0.3246 ⁢ φ + 46.435 2 ⁢ 1 - φ; or 1 - φ ⁢ 4 ⁢ L opt 2 + w 1 - w 1 ⁢ φ 2 - 1 w 1 = - 0.1327 ⁢ φ 2 - 5.1189 ⁢ φ + 1 where φ = w 2 / w 1. a length Lopt of each isosceles trapezoid; a minimum width w1 at the anchor; and a maximum width w2 at a free end of the resonator, a distance from the anchor, wherein the width of the resonator tapers gradually along its entire length from the maximum width to the minimum width, and wherein the dimensions of the resonator satisfy one of the following two equations: L opt w 1 = - 0.1327 ⁢ φ - 0.3246 ⁢ φ + 46.435 2 ⁢ 1 - φ; or 1 - φ ⁢ 4 ⁢ L opt 2 + w 1 - w 1 ⁢ φ 2 - 1 w 1 = - 0.1327 ⁢ φ 2 - 5.1189 ⁢ φ + 1 where φ = w 2 / w 1.
A compound having the formula I: or a pharmaceutically acceptable salt thereof, wherein R 1 is hydrogen, -OH, -O-C 1 - 6 alkyl, =O, or halogen; R2 is hydrogen, -C OR 8, -C 6 H 5 C OR 8, -(CH 2) 1-2 OH, -CR 9 R 10 OH, -C O(CH 2) 0-2 aryl, -C NR 9 R 10, -C SO 2 NR 9 R 10, -C 6 H 5 OR 9, -W-C OR 8, -W-OR 9, -Y, or -P (OR 9)(OR 10); R3 is hydrogen or -C 1-6 alkyl; R 4 is hydrogen, -OH, or -C OR 9; R 5 is hydrogen or deuterium; R 6 and R 7 are independently -C 1-6 alkyl, fluoro-substituted -C 1-6 alkyl, deutero-substituted -C 1-6 alkyl or -(CH 2) 1-2 R 11, wherein any carbon atom of the fluoro-substituted -C 1-6 alkyl is mono- or di-substituted with fluoro, and any carbon atom of the deutero-substituted -C 1-6 alkyl is mono- or di-substituted with fluoro; R 8, in each instance in which it occurs, hydrogen, -C 1-6 alkyl, or -(CH 2) 2 N + (CH 3) 3; R9 and R 10, in each instance in which they occur, are independently -C 1-6 alkyl; R 11 is -OH, -O-C 1-6 alkyl, -OCD3, -OC OC 1-6 alkyl, -NH 2, -C 6 H 5, -N 3, or W; W is an unsubstituted 5- or 6-membered heteroaryl ring having 1, 2, or 3 nitrogen atoms, or a substituted 5- or 6-membered heteroaryl ring having 1, 2, or 3 nitrogen atoms that is mono- or di-substituted at any carbon atom with R 6 or R 7; Y is a 5- or 6-membered heterocyclic ring having 1, 2, 3 or 4 heteroatoms which are N, O or S, or stereoisomers thereof, or pharmaceutically acceptable salts thereof, or pharmaceutically acceptable salts of stereoisomers thereof. R 1 is hydrogen, -OH, -O-C 1 - 6 alkyl, =O, or halogen; R2 is hydrogen, -C OR 8, -C 6 H 5 C OR 8, -(CH 2) 1-2 OH, -CR 9 R 10 OH, -C O(CH 2) 0-2 aryl, -C NR 9 R 10, -C SO 2 NR 9 R 10, -C 6 H 5 OR 9, -W-C OR 8, -W-OR 9, -Y, or -P (OR 9)(OR 10); hydrogen, -C OR 8, -C 6 H 5 C OR 8, -(CH 2) 1-2 OH, -CR 9 R 10 OH, -C O(CH 2) 0-2 aryl, -C NR 9 R 10, -C SO 2 NR 9 R 10, -C 6 H 5 OR 9, -W-C OR 8, -W-OR 9, -Y, or -P (OR 9)(OR 10); R3 is hydrogen or -C 1-6 alkyl; R 4 is hydrogen, -OH, or -C OR 9; R 5 is hydrogen or deuterium; R 6 and R 7 are independently -C 1-6 alkyl, fluoro-substituted -C 1-6 alkyl, deutero-substituted -C 1-6 alkyl or -(CH 2) 1-2 R 11, wherein any carbon atom of the fluoro-substituted -C 1-6 alkyl is mono- or di-substituted with fluoro, and any carbon atom of the deutero-substituted -C 1-6 alkyl is mono- or di-substituted with fluoro; R 8, in each instance in which it occurs, hydrogen, -C 1-6 alkyl, or -(CH 2) 2 N + (CH 3) 3; R9 and R 10, in each instance in which they occur, are independently -C 1-6 alkyl; R 11 is -OH, -O-C 1-6 alkyl, -OCD3, -OC OC 1-6 alkyl, -NH 2, -C 6 H 5, -N 3, or W; W is an unsubstituted 5- or 6-membered heteroaryl ring having 1, 2, or 3 nitrogen atoms, or a substituted 5- or 6-membered heteroaryl ring having 1, 2, or 3 nitrogen atoms that is mono- or di-substituted at any carbon atom with R 6 or R 7; Y is a 5- or 6-membered heterocyclic ring having 1, 2, 3 or 4 heteroatoms which are N, O or S, or stereoisomers thereof, or pharmaceutically acceptable salts thereof, or pharmaceutically acceptable salts of stereoisomers thereof.
Effector device for engaging a target using electromagnetic pulses, comprising a source unit (2, 2a, 2b) designed to emit the pulses and a parachute (3, 3a, 3b), to which the source unit (2, 2a, 2b) is fastened, characterized in that the effector device (1, 1a, 1b, 1c, 1d, 1e, 1f) additionally has a reflector unit (6, 6a, 6b, 6c, 6d, 6e) which is arranged separately from a parachute surface (5, 5a, 5b) of the parachute in a falling operating position with the parachute (3, 3a, 3b) open and is designed to reflect electromagnetic pulses, emitted by the source unit (2, 2a, 2b, 2c, 2d, 2e), in the direction of the target.
A bent edge of a metal sheet, wherein the bent edge is embodied in the form of a smooth, harmonic, assembled mathematical cubic curve (spline or polynomial line), characterised in that the bending of the edge of the metal sheet takes place in the visually relevant outer region of a vehicle in the movable region of doors (1, 2) or gates, in order to make the point of separation between moving and fixed parts (1, 2) appear visually narrower.